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antimicrobial resistance in Iran is different from other parts ofnfections in children:  a referra
ear Editor,
acterial pathogens are becoming more  and more  resistant
o  antibiotics used commonly by healthcare practitioners.
espite introduction of new antibiotics, empiric treatment of
atients  with bloodstream infections (BSIs) became a major
hallenge  for practicing physicians.1,2
To depict the susceptibility patterns of BSI pathogens
ndemic in a referral pediatric hospital, Children’s Med-
cal  Center (Tehran, Iran), the antimicrobial susceptibility
atterns among 3593 patients were reviewed in a 5-year
eriod  (2006–2010). Bacterial identiﬁcation and disk diffu-
ion  susceptibility testing were performed, using standard
ethods.3
Percentages of Gram positive and Gram negative bacte-
ia  were  35% (1265/3593) and 65% (2328/3593), respectively.
nterobacter spp. (25.9%), Pseudomonas aeroginosa (25.5%), and
oagulase-negative staphylococci (CoNS) (23.2%) were the most
requent  agents, followed by Staphylococcus aureus (6.2%) and
lebsiella  spp. (5.9%), collectively accounting for 87% of all BSI
lood  isolates cultured. were Staphylococcus spp., followed by
iridans group streptococci, Streptococcus pneumonia, and Entro-
occus  spp. comprised about 84% of all Gram positive bacteria
solated  from blood cultures. Among Gram negative bacte-
ia,  Enterbacter spp., Pseudomonas aeruginosa, Klebsiella spp., E.
oli, and Salmonella spp. accounted for about 95% of isolates.
able  1 shows the antimicrobial susceptibility pattern of Gram
ositive  and Gram negative bacteria in this study. CoNS are
lmost  always resistant to oxacillin. Furthermore, the rate
Table 1 – Antimicrobial susceptibility proﬁle of isolated bacteria
Bacteria Antimicrobial 
Gram positive bacteria
Viridans  group streptococci Ceftriaxone 
Clindamycin 
Chloramphenicol 
Erythromycin
Penicillin 
Vancomycin 
Enterococcus spp. Chloramphenicol 
Erythromycin hospital-based  study
of susceptibility is very low among S. aureus (13.2%) and S.
pneumoniae  (7%). Vancomycin showed an acceptable antibi-
otic  effect on CoNS, S. aureus, S. pneumoniae and viridans
group Streptococci, with susceptibility rates of 93.2%, 95.3%,
96.4%  and 92.7%, respectively. Among staphylococcal isolates
S.  aureus was  more  susceptible to clindamycin (82.9% versus
52.9%)  and to trimethoprim/sulfamethoxazole (60.9% versus
34.0%)  than CoNS. S. pneumoniae was  highly susceptible to cef-
triaxone  (93.9%), cefalotin (96.6%), and vancomycin (96.4%).
About  half of the Klebsiella spp. isolates tested were  resistant
to  amikacin. The rate of resistance to ampicillin, ceftriaxone
and  piperacillin-tazobactam was  as high as 97.7%, 66.7% and
35.4%,  respectively. The rate of E. coli resistance to amikacin
was  similar to that of Klebsiella spp. On the contrary, Imipenem
showed  to be quite effective in both organisms (Table 1).
Although  bacteriologic culture is the keystone of man-
agement of septicemia, culture result takes time; therefore,
understanding the regional bacterial susceptibility and pat-
tern  of resistance to antimicrobial agents is very important
to  prepare treatment guidelines. In two previous studies con-
ducted  in the same hospital during 1995–2000 and 2001–2005,
the  prevalence of Gram positive bacteria was  reported as 72.0%
and  47.6%, respectively.4,5 However, the recent data showed
that  the Gram negative microorganisms have become much
more  prevalent. These data also show that the pattern of.
Total no. Percent susceptible
71.6 67
67 77.6
40 82.5
65 52.3
37 40.5
110 92.7
13 69.2
17 11.8
the  world. Thus, based on the observed changes therapeutic
regimens prescribed by health practitioners in Iran should be
modiﬁed.
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Table 1 (Continuación )
Bacteria Antimicrobial Total no. Percent susceptible
Gentamicin 28 25
Penicillin 12 8.3
Vancomycin 29 62.1
Gram negative bacteria
Klebsiella  spp. Amikacin 148 48.0
Ampicillin 133 2.3
Ceftriaxone 129 33.3
Cefalotin 153 11.8
Chloramphenicol 82 52.4
Trimethoprim/sulfamethoxazole 178 57.3
Gentamicin 206 44.2
Imipenem 76 97.3
Cefepime 141 73.0
Ceftazidime 121 67.8
Escherichia coli Amikacin 71 53.0
Ampicillin 63 12.7
Ceftriaxone 64 50.0
Cefalotin 87 33.3
Chloramphenicol 43 79.1
Trimethoprim/sulfamethoxazole 100 27.0
Gentamicin 108 61.1
Imipenem 33 97.0
Tobramycin 66.7 36.0
Piperacillin-Tazobactam 91 70.3
Pseudomonas aeruginosa Amikacin 617 39.4
Ceftazidime 558 16.3
Ceftriaxone 547 7.9
Chloramphenicol 456 30.2
Ciproﬂoxacin 481 94.6
Gentamycin 904 41.6
Kanamycin 473 4.6
Imipenem 91 68.1
Tobramycin 329 30.7
Enterobacter spp. Amikacin 715 93.4
Ampicillin 708 4.1
Ceftriaxone 679 92.3
Chloramphenicol 695 85.5
Ciproﬂoxacin 693 99.4
Trimethoprim/sulfamethoxazole 847 92.9
Gentamicin 867 93.5
Kanamycin 577 76.1
Imipenem 23 87.0
Tobramycin 507 94.1
Piperacillin-Tazobactam 343 73.8
Salmonella spp. Amikacin 24 100
Ampicillin 21 71.4
Cefalotin 24 87.5
Chloramphenicol 10 90.0
Trimethoprim/sulfamethoxazole 31 83.9
Kanamycin 9 88.8
Gentamicin 36 94.4
Imipenem 6 100
Tobramycin 10 100
Piperacillin-Tazobactam 31 71.0
Acinetobacter spp. Amikacin 12 58.3
Chloramphenicol 6 50.0
Kanamycin 7 28.6
Gentamicin 18 66.7
Tobramycin 6 33.3
Haemophilus spp. Amikacin 12 66.7
Ceftriaxone 10 80.0
Chloramphenicol 7 71.4
Trimethoprim/sulfamethoxazole 19 36.8
Kanamycin 6 33.3
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Table 1 (Continuación )
Bacteria Antimicrobial Total no. Percent susceptible
Gentamicin 20 65.0
Imipenem 4 100
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5Penicillin 
Tobramycin 
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